16-58516083-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001160305.4(SETD6):c.320G>A(p.Gly107Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000198 in 1,416,708 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001160305.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SETD6 | NM_001160305.4 | c.320G>A | p.Gly107Asp | missense_variant | 2/8 | ENST00000219315.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SETD6 | ENST00000219315.9 | c.320G>A | p.Gly107Asp | missense_variant | 2/8 | 1 | NM_001160305.4 |
Frequencies
GnomAD3 genomes AF: 0.0000134 AC: 2AN: 148784Hom.: 0 Cov.: 29
GnomAD3 exomes AF: 0.0000395 AC: 2AN: 50682Hom.: 0 AF XY: 0.0000687 AC XY: 2AN XY: 29112
GnomAD4 exome AF: 0.0000189 AC: 24AN: 1267814Hom.: 0 Cov.: 40 AF XY: 0.0000209 AC XY: 13AN XY: 621420
GnomAD4 genome AF: 0.0000269 AC: 4AN: 148894Hom.: 0 Cov.: 29 AF XY: 0.0000413 AC XY: 3AN XY: 72600
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 24, 2024 | The c.320G>A (p.G107D) alteration is located in exon 2 (coding exon 2) of the SETD6 gene. This alteration results from a G to A substitution at nucleotide position 320, causing the glycine (G) at amino acid position 107 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at